Dutch firm Argenx files for $75M IPO on Nasdaq

|About: Argen X NV (ARGNF)|By:, SA News Editor

Dutch drugmaker Argenx (OTC:ARGNF) has filed for a U.S. initial public offering of up to $74.8M.

The company, which engages in the provision of development of therapeutic antibodies for the treatment of cancer and severe autoimmune diseases, wants to list American Depositary Shares on Nasdaq under the symbol ARGX.

Underwriters are Cowen and Co., Piper Jaffray, JMP Securities and Wedbush Pacgrow.

Shares closed down 1.1% today in Brussels.